Jetflam-AS Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100 mg), Paracetamol (325 mg), and Serratiopeptidase (15 mg). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides effective relief from pain and inflammation by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis. Paracetamol acts as an analgesic and antipyretic, offering symptomatic relief from mild to moderate pain and fever through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, facilitates the reduction of inflammation and edema by breaking down inflammatory mediators and promoting tissue repair. This synergistic combination is indicated for the management of musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and soft tissue injuries including sprains and strains. Jetflam-AS Tablet is also beneficial in postoperative and dental pain management due to its potent anti-inflammatory and analgesic properties. The medication should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, and severe hepatic or renal impairment. Patients are advised to follow prescribed dosages to minimize adverse effects like gastrointestinal discomfort, allergic reactions, or potential bleeding risks. Jetflam-AS offers a comprehensive approach to pain and inflammation control, improving patient comfort and mobility.